The short version of ghrelin receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-24 and is reviewed periodically as new material appears.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentapeptide | Chain of five amino acid residues |
| Molecular mass | Approximately 712 Da | Consistent with a five-residue chain |
| Receptor target | GHS-R1a | Growth hormone secretagogue receptor |
| Primary action | Growth hormone release | Pituitary somatotroph stimulation |
| Research origin | Developed in the 1990s | Small-peptide secretagogue program |
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The first emergence of mesenchyme occurs during gastrulation from the epithelial–mesenchymal transition (EMT) process. This transition occurs through the loss of epithelial cadherin, tight junctions, and adherens junctions on the cell membranes of epithelial cells. The surface molecules undergo endocytosis and the microtubule cytoskeleton loses shape, enabling mesenchyme to migrate along the extracellular matrix (ECM). Epithelial–mesenchymal transition occurs in embryonic cells that require migration through or over tissue, and can be followed with a mesenchymal–epithelial transition to produce secondary epithelial tissues. Embryonic mesenchymal cells express protein S100-A4 (S100A4), also known as fibroblast-specific protein, which is indicative of their shared properties with the migratory adult fibroblasts, and c-Fos, an oncogene associated with the down-regulation of epithelial cadherin. Formation of both the primitive streak and mesenchymal tissue depend on the Wnt/β-catenin pathway. Specific markers of mesenchymal tissue include the additional expression of ECM factors such as fibronectin and vitronectin.
Often, as a last resort, if other treatments have failed, the most common procedure is prosthetic implants which involves the insertion of artificial rods into the penis. Some sources show that vascular reconstructive surgeries are viable options for some people.
=== Das Buch der von Neil Young Getöteten (2002) === Kermani's first literary text appeared in 2002: „Das Buch der von Neil Young Getöteten“ [The Book of Those Killed by Neil Young] which combines three themes: first, the music of Neil Young, to whose songs numerous song interpretations are dedicated; second, the astonishing therapeutic effect of Neil Young’s music on the first-person narrator's daughter while suffering from three-month colic and during her first year of life; and third, the narrator's biography, which has been significantly influenced by Neil Young (whose importance to the narrator is as obvious as the narrator’s tendency toward ironic exaggeration). Omnipresent (self-)irony as the book’s foremost narrative principle allows the narrator to integrate the major literary themes, ranging from God to love to death, into the flow of his narration without making the text seem overloaded. Whereas the first half of the text is shaped by philosophical and literary reminiscences where Neil Young's lyrics undergo exacting philological analysis, the second half focuses on the mystical dimensions that the narrator regards as constituting the core of Neil Young's music and of his own listening experience. The enigmatic title of the book refers to „The Book of Those Killed by the Koran“, an historic manuscript that tells of mystics who heard the Koran and died as a result. For the narrator, this calls to mind the existential significance of Neil Young's music for his own life, giving him the impulse to write the Neil Young book in the first place.
Direct-to-consumer blood testing (DTC blood testing), also known as direct access testing (DAT), is a form of laboratory testing that allows consumers to order blood tests directly from a clinical laboratory without requiring a prescription or referral from a physician. This market has grown significantly in recent years, driven by consumer interest in personalized health management, advances in laboratory technology, and regulatory changes that have expanded access in many jurisdictions. These services typically offer comprehensive metabolic panels, lipid profiles, hormone testing, nutritional markers, and increasingly sophisticated biomarker assessments that were traditionally only available through healthcare providers. Over the last decade, a paradigm shift has taken place with consumers seeking greater involvement in decisions affecting their healthcare and with policies that enable this involvement.
In the sense that DNA replication must occur if genetic material is to be provided for the progeny of any cell, whether somatic or reproductive, the copying from DNA to DNA arguably is the fundamental step in information transfer. A complex group of proteins called the replisome performs the replication of the information from the parent strand to the complementary daughter strand.
Sources: en.wikipedia.org
A 2005 meta-analysis of drug company data found no evidence that SSRIs increased the risk of suicide; however, important protective or hazardous effects could not be excluded. A 2005 review observed that suicide attempts are increased in those who use SSRIs as compared to placebo and compared to therapeutic interventions other than tricyclic antidepressants. No difference risk of suicide attempts was detected between SSRIs versus tricyclic antidepressants. A 2006 review suggests that the widespread use of antidepressants in the new "SSRI-era" appears to have led to a highly significant decline in suicide rates in most countries with traditionally high baseline suicide rates. The decline is particularly striking for women who, compared with men, seek more help for depression. Recent clinical data on large samples in the US, too, have revealed a protective effect of antidepressants against suicide. A 2006 meta-analysis of randomized controlled trials suggests that SSRIs increase suicide ideation compared with placebo. However, the observational studies suggest that SSRIs did not increase suicide risk more than older antidepressants. The researchers stated that if SSRIs increase suicide risk in some patients, the number of additional deaths is small because ecological studies have generally found that suicide mortality has declined (or at least not increased) as SSRI use has increased. An additional meta-analysis by the FDA in 2006 found an age-related effect of SSRIs. Among adults younger than 25 years, results indicated that there was a higher risk for suicidal behavior.
In 1998 Andrew Wakefield et al. published a fraudulent paper about twelve children, reportedly with bowel symptoms and autism or other disorders acquired soon after administration of MMR vaccine, while supporting a competing vaccine. In 2010, Wakefield's research was found by the General Medical Council to have been "dishonest", and The Lancet fully retracted the paper. Three months following The Lancet's retraction, Wakefield was struck off the UK medical register, with a statement identifying deliberate falsification in the research published in The Lancet, and was barred from practising medicine in the UK. The research was declared fraudulent in 2011 by the British Medical Journal. Since Wakefield's publication, multiple peer-reviewed studies have failed to show any association between the vaccine and autism. The US Centers for Disease Control and Prevention, the Institute of Medicine of the US National Academy of Sciences, the UK National Health Service and the Cochrane Library review have all concluded that there is no evidence of a link. Administering the vaccines in three separate doses does not reduce the chance of adverse effects, and it increases the opportunity for infection by the two diseases not immunized against first. However, on August 10, 2026, US president Donald Trump signed an executive order requiring the MMR vaccine to be split into three separate shots, and recommending that "to the maximum extent feasible, all childhood immunizations should be administered at separate medical visits".
Common descent is a concept in evolutionary biology applicable when one species is the ancestor of two or more species later in time. According to modern evolutionary biology, all living beings could be descendants of a unique ancestor commonly referred to as the last universal common ancestor (LUCA) of all life on Earth. Common descent is an effect of speciation, in which multiple species derive from a single ancestral population. The more recent the ancestral population two species have in common, the more closely they are related. The most recent common ancestor of all currently living organisms is the last universal ancestor, which lived about 3.9 billion years ago. The two earliest pieces of evidence for life on Earth are graphite found to be biogenic in 3.7 billion-year-old metasedimentary rocks discovered in western Greenland and microbial mat fossils found in 3.48 billion-year-old sandstone discovered in Western Australia. All currently living organisms on Earth share a common genetic heritage, though the suggestion of substantial horizontal gene transfer during early evolution has led to questions about the monophyly (single ancestry) of life. 6,331 groups of genes common to all living animals have been identified; these may have arisen from a single common ancestor that lived 650 million years ago in the Precambrian. Universal common descent through an evolutionary process was first proposed by the British naturalist Charles Darwin in the concluding sentence of his 1859 book On the Origin of Species:
The Port of Le Havre and the light on the estuary of the Seine inspired many painters: Louis-Philippe Crepin (1772–1851), Jean-Baptiste Corot (1796–1875), Eugène Isabey (1803–1886), Theodore Gudin (1802–1880), Adolphe-Felix Cals (1810–1880), Jean-François Millet (1814–1875) in 1845, Gustave Courbet (1819–1877) etc.. It is to Eugène Boudin (1824–1898) who created many representations of Le Havre in the 19th century. The artist lived for a time in the city. Thanks to its proximity to Honfleur, Le Havre was also represented by foreign artists such as William Turner, Johan Barthold Jongkind, Alfred Stevens, and Richard Parkes Bonington.
Sources: en.wikipedia.org
) and a high filling factor, resulting in a strong coupling between the probe coil and the sample. The phenomenon is also impacted by the concentration of the nuclei within the sample and their magnetic moments, which can intensify the effects of radiation damping. The strength of the magnetic field is inversely proportional to the lifetime of RD. The impact of radiation damping on NMR signals is multifaceted. It can accelerate the decay of the NMR signal faster than intrinsic relaxation processes would suggest. This acceleration can complicate the interpretation of NMR spectra by causing broadening of spectral lines, distorting multiplet structures, and introducing artifacts, especially in high-resolution NMR scenarios. Such effects make it challenging to obtain clear and accurate data without considering the influence of radiation damping. To mitigate these effects, various strategies are employed in NMR spectroscopy. These methods majorly stem from hardware or software. Hardware modifications including RF feed-circuit and Q-factor switches reduce the feedback loop between the sample magnetization and the electromagnetic field induced by the coil and function successfully. Other approaches such as designing selective pulse sequences also effectively manage the fields induced by radiation damping. These approaches aim to control and limit the disruptive effects of radiation damping during NMR experiments and all approaches are successful in eliminating RD to a fairly large extent.
Laserspray inlet ionization (LSII) is a subset of MAII and uses a matrix-assisted laser desorption/ionization (MALDI) method. It was originally called atmospheric pressure matrix-assisted laser desorption/ionization however was renamed as LSII to avoid confusion with MALDI and as it was found to be a type of inlet ionization. As all inlet ionization techniques, highly multiply charged ions are produced. A nitrogen laser is used to ablate the solid matrix/analyte into the heated inlet tube, the observed ions are generated at the surface of the matrix/analyte and so the laser is not directly involved in the ionization as was originally thought. LSII can determine protein molecular weights and has been found to detect masses of proteins up to 20,000 Da. The sensitivity of LSII, for protein detection, is higher by an order of magnitude compared to ESI.
60 years after the events of The Matrix Revolutions, Neo is now a video game designer and the creator of a video game series simply known as The Matrix, which uses Neo's previous memories in the plot. Neo is 57 years old in the Matrix program, but 60 years have passed in the real world, making Neo 97 years old. Neo once again lives under the alias Thomas Anderson and although he does not look old, others see him as an aging man with long gray hair. His love, Trinity, who lives under the name "Tiffany", is married to a man named Chad and has three children. Neo has a existential crisis, so his therapist has prescribed him the blue pills. Neo's boss approaches him with an idea to make a fourth Matrix game. However, the more Neo and his crew make the game, the less blue pills he takes and he eventually stops taking them. One day, a man known as "Morpheus" approaches Neo with the red pill, but agents and a police force storm the building where Neo works in order to kill Morpheus, who is revealed as a rogue agent who opened his mind and decided to help Neo destroy the Matrix (and has taken on the identity of the original Morpheus, who has since died). Morpheus kills several police officers while Neo's boss picks up an officer's gun and once again becomes Agent Smith. The attack was revealed to be a dream, and Neo was still in his therapist's room. A drunk Neo later goes on a rooftop and questions his existence. However, a woman with blue hair and a trench coat appears besides him. The woman introduces herself as Bugs, who tries to reopen his mind through a White Rabbit tattoo.
Sources: en.wikipedia.org
It acts on the growth hormone secretagogue receptor, GHS-R1a, which is also the receptor for ghrelin. Binding triggers intracellular signaling that promotes growth hormone release from the pituitary. The interaction is the basis for its classification as a secretagogue.
In animal studies it showed greater selectivity for growth hormone release, with less effect on cortisol and adrenocorticotropic hormone than compounds such as GHRP-6. This selectivity is one of the most frequently cited features in preclinical literature. Whether the same profile applies in other contexts is not fully established.
The receptor-level events are reasonably well described, but the full range of downstream effects is not. Studies have reported activity in tissues beyond the pituitary, including the gut. How these observations translate across species and conditions remains an open question.
It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.